The FDA has granted Endologix expanded approval for its AFX endovascular system used to treat abdominal aortic aneurysms, along with the company's IntuiTrak Powerlink technology. The device is now approved for use in percutaneous endovascular aneurysm repair procedures and could be available for physician training in the U.S. as early as the second quarter.

Related Summaries